A R T I C L E S
Hanes et al.
Scheme 1. Substrates Used by Pdx1 and Pdx2 in the Formation
of PLP
over CaH2 when noted as dry. Proton and carbon NMR were recorded
on a Bruker ARX-300.
Preparation of Deuteroribose Derivative 9 (Scheme 2). (-)-
Isoborneol-1-2H (1.6 g, 10.5 mmol)19 was dissolved in dry ether (4
mL) and added to a previously prepared solution of n-butylmagnesium
bromide [n-butyl bromide (1.2 mL, 11.4 mmol) in dry ether (4 mL)
was added slowly to Mg in ether (4 mL) followed by 1 h of reflux].
After 30 min, dry benzene (13 mL) was added and the ether was
distilled through a vigreux column under argon. Aldehyde 816 (195
mg, 0.70 mmol) was dissolved in dry benzene (2.5 mL) and added to
the prepared reagent. After refluxing for 3 h, the solution was cooled
and treated with 0.1 N HCl (∼30 mL) and dichloromethane (30 mL).
The layers were separated, and the organic phase was washed with
saturated NaHCO3 and brine. After drying over MgSO4, evaporation
of solvent was followed by column chromatography with 25% EtOAc
in hexanes to provide the alcohol 9 (109 mg, 55% yield) as an oil; 1H
NMR (300 MHz, CDCl3) δ 7.40-7.26 (m, 5H), 5.72 (d, J ) 3.7 Hz,
1H), 4.76 (d, J ) 11.9 Hz, 1H), 4.58 (d, J ) 11.9 Hz, 1H), 4.59-4.55
(m, 1H), 4.10 (dd, J ) 3.1, 9.1 Hz, 1H), 3.84 (dd, J ) 4.3, 9.1 Hz,
1H), 3.60 (dd, J ) 2.5, 8.4 Hz, 1H), 1.83 (d, J ) 8.6 Hz, 1H), 1.59 (s,
3H), 1.36 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 137.5, 128.4, 128.0,
127.9, 113.0, 104.0, 78.6, 77.4, 76.5, 72.3, 60.2 (t, J ) 21.5 Hz), 26.8,
26.4.
the presence of G3P15 and is covalently attached to the protein
via Lys 81.16 MS analysis of the labeled peptide indicated a
mass increase of 95 Da which is consistent with loss of water
and phosphate from a Ru5P-Pdx1 adduct. Here we provide
additional information regarding this intermediate that enables
us to further narrow down the mechanistic possibilities for PLP
formation. Specifically, we are able to monitor the production
of the intermediate under mild conditions using ESI-FTMS,
observe a primary deuterium kinetic isotope effect at C5 of R5P
on the formation of the intermediate, and determine that this
isotope effect is due to removal of the pro-R proton. We also
demonstrate that ammonia is covalently incorporated into the
intermediate and that G3P is a much better substrate than
dihydroxyacetone-phosphate (DHAP). Additionally, we show
that phosphate loss occurs by an elimination reaction rather than
by a hydrolysis reaction and that this occurs after C5 deproto-
nation and ammonia addition.
Conversion of Alcohol 9 into (5S)-[5-2H1]-Ribose 4. The alcohol
9 (32 mg, 0.11 mmol) was dissolved in AcOH (2 mL) and treated with
10% Pd/C (10 mg). Stirring was maintained under a balloon of H2 for
3 h, and the reaction mixture was then filtered through Celite.
Evaporation of the solvent followed by column chromatography on
silica gel (3% MeOH in CHCl3) afforded the diol 10 (21.5 mg, 99%)
1
as an oil; H NMR (300 MHz, CDCl3) δ 5.80 (d, J ) 3.8 Hz, 1H),
4.57 (t, J ) 4.7 Hz, 1H), 4.05-3.95 (m, 1H), 3.82 (dd, J ) 3.8, 8.9
Hz, 1H), 3.75-3.68 (m, 1H), 2.60 (d, J ) 10.4 Hz, 1H), 2.24 (br s,
1H), 1.56 (s, 3H), 1.36 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 112.7,
103.9, 80.5, 78.7, 70.8, 60.4 (t, J ) 24.2 Hz), 26.48, 26.45.
The diol 10 (21 mg, 0.11 mmol) was taken up in H2O (3 mL) and
treated with Dowex-50W resin (25 mg previously washed with 10%
HCl, water, EtOH, and diethyl ether) at 50 °C. After 24 h, the resin
was filtered off, NH4OH was added, and the filtrate was lyophilized to
provide (5S)-[5-2H1]-ribose 4 (16 mg, 96%) as an oily solid; 1H NMR
(300 MHz, D2O) (chemical shifts for R- and â-pyranose and furanose)
δ 5.38-5.20 and 4.90-4.80 (m, 1H), 4.20-4.07 (m, 1H), 3.89-3.78
(m, 2H), 3.70-3.47 (m, 1H); 13C NMR (75 MHz, D2O) (chemical shifts
for R- and â-pyranose and furanose) δ 101.2, 96.0, 94.0, 93.8, 83.5,
83.2, 75.3, 71.3, 70.7, 70.3, 69.5, 69.3, 67.6, 67.4, 63.3 (t, J ) 23.4
Hz).
Experimental Section
Protein Overexpression and Purification. Overexpression and
purification were performed as previously published13 except for the
following changes. A 1 mL HisTrap HP column (GE Healthcare Bio-
Sciences Corp. Piscataway, NJ) was used according to the product
literature. Subsequent to elution of Pdx1 and Pdx2 from the column
the protein was buffer exchanged into the following buffer system:
50 mM Tris (Trizma base) pH 8.0 @ RT, 100 mM NaCl, 2 mM TCEP,
and 10% glycerol using an Econo-Pac 10DG desalting column (Bio-
Rad Laboratories, Hercules, CA). A portion of Pdx1 and Pdx2 were
combined at this time and used for experiments where both were
necessary. The two proteins were mixed at a 1:1.5 molar ratio (Pdx1:
Pdx2) according to the Coomassie Plus Assay Reagent (Pierce
Biotechnology, Rockford, IL). To free the enzyme from the bound Ru5P
adduct that copurifies with Pdx1, 10 mM glutamine and 1 mM G3P
were added and allowed to incubate overnight at 4 °C. For samples
containing only Pdx1, 50 mM NH4Cl was added in place of the
glutamine. After the overnight incubation, the samples were again
purified using the HisTrap procedure as detailed above, and subsequent
to elution the proteins were buffer exchanged into 50 mM HEPES pH
7.5 @ RT, 100 mM NaCl, 2 mM TCEP, and 20% glycerol. 30 µL
aliquots of protein were flash frozen using liquid nitrogen and stored
at -80 °C. Control reactions demonstrated that this method of enzyme
storage did not result in any activity loss.
Inversion of Configuration at the 5-Position of 9 (Scheme 3).
Alcohol 9 (47 mg, 0.17 mmol) was dissolved in THF (5 mL) followed
by addition of PPh3 (175 mg, 0.67 mmol) and p-nitrobenzoic acid (112
mg, 0.67 mmol). After cooling to 0 °C, DEAD (116 mg, 0.67 mmol)
was added dropwise and the solution was slowly warmed to room
temperature. After 4 h, the solution was evaporated to an oil and
chromatographed on silica with 10% EtOAc in hexanes to provide the
p-nitrobenzoate ester 11 (72 mg).
The ester (72 mg, 0.17 mmol) was then dissolved in MeOH (3 mL)
and treated with K2CO3 at room temperature. Evaporation of solvent
followed by chromatography on silica gel (30% EtOAc in hexanes)
provided the inverted alcohol 12 (46 mg, 99% over two steps); 1H NMR
(300 MHz, CDCl3) δ 7.40-7.31 (m, 5H), 5.71 (d, J ) 3.6 Hz, 1H),
4.75 (d, J ) 11.9 Hz, 1H), 4.58 (d, J ) 11.9 Hz, 1H), 4.56-4.52 (m,
1H), 4.10 (dd, J ) 2.5, 9.1 Hz, 1H), 3.90-3.88 (m, 1H), 3.83 (dd, J )
4.3, 9.1 Hz, 1H), 1.90 (br s, 1H), 1.59 (s, 3H), 1.36 (s, 3H); 13C NMR
Synthesis of (5S)-[5-2H1]- and (5R)-[5-2H1]-Ribose. The ribose
diastereomers 4 and 5 were prepared from the known alcohol 9 using
a modified procedure.17,18 All solvents were reagent grade and distilled
(17) Kundu, M. K.; Foldesi, A.; Chattopadhyaya, J. HelV. Chim. Acta 2003,
86, 633-642.
(18) Ono, A.; Ono, A.; Kainosho, M. Tetrahedron Lett. 1997, 38, 395-398.
(19) Crich, D.; Neelamkavil, S. PCT/US2002/019274(WO/2003/002526), 41 pp.
2003. Ref Type: Patent.
(15) Burns, K. E. Dissertation, 2006, Cornell University. Ref Type: Thesis/
Dissertation.
(16) Raschle, T.; Arigoni, D.; Brunisholz, R.; Rechsteiner, H.; Amrhein, N.;
Fitzpatrick, T. B. J. Biol. Chem. 2007, 282, 6098-6105.
9
3044 J. AM. CHEM. SOC. VOL. 130, NO. 10, 2008